Diagnostic Value of Serum Markers Combined with TVCDS in Ovarian Cancer Patients Treated with Bushen Yiqi Quyu Prescription

Table 3

Comparison of serum tumor markers in patients with different stages of OC.

Clinical stage	n	HE4 (pmol/L)	COX-1 (U/mL)
I	56	193.52 ± 41.64	46.32 ± 8.65
II	69	227.83 ± 43.12	65.94 ± 9.28
III	84	278.96 ± 38.57	91.76 ± 11.37
IV	23	353.67 ± 32.86	136.54 ± 13.71
t		8.623	7.540
		<0.05	<0.05